This is a plain-English translation of the academic paper above, prepared for patients, referring clinicians, and other non-specialist readers. It preserves the structure of the original paper while removing technical jargon. For the full clinical paper, follow the PubMed or DOI links.
Background
The biological steps that lead a damaged growth plate to form a “bone bridge” — an unwanted band of bone across the cartilage that allows children’s bones to lengthen. Specifically, we tracked a key signalling protein (VEGF) and the new blood vessels it promotes, in a rat model of growth-plate injury.
Rationale
When a child injures a growth plate, it can heal normally or it can form a fixed bone bridge that arrests growth on one side, producing a limb that grows shorter or develops an angle. Understanding the cellular signals that drive bridge formation could one day allow surgeons to interrupt the process before it becomes permanent.
Results
Bone-bridge formation was preceded and accompanied by an ingrowth of new blood vessels (angiogenesis), and this was driven by VEGF and one of its receptors. The bone debris in the early haematoma was itself VEGF-positive and seemed to keep the angiogenic signal going. By day 28 a clearly-formed bone bridge was visible, both microscopically and on MRI.
Implications
This is laboratory research, not a treatment in itself. It maps out a window of opportunity — the first weeks after injury, when angiogenesis is taking off — during which a future therapy might block the formation of a damaging bone bridge. Translating that into a clinical intervention will take further work.
Source: Fischerauer E, Heidari N, Neumayer B, Deutsch A, Weinberg AM. The spatial and temporal expression of VEGF and its receptors 1 and 2 in post-traumatic bone bridge formation of the growth plate. Journal of Molecular Histology 2011;42(6):513-22. doi:10.1007/s10735-011-9359-x
Read original on PubMed → ← Back to research library